Literature DB >> 8094728

Exogenous antigens internalized through transferrin receptors activate CD4+ T cells.

K L McCoy1, M Noone, J K Inman, R Stutzman.   

Abstract

The role of endosomes in exogenous Ag processing was investigated by targeting Ag into the endosomal transport pathway via transferrin receptors. The Ag, pigeon cytochrome c and chicken OVA, were coupled to human ferric transferrin by a heteroligation technique. The conjugates were significantly more efficient than native Ag in stimulating Ag-specific CD4+ T cells, when the APC expressed transferrin receptors. The addition of ferric transferrin eliminated the enhanced response. Paraformaldehyde-fixed APC did not present the conjugates, indicating that the conjugates still required processing to activate T cells. An augmented level of T cell activation was not observed when the APC lacked transferrin receptors or when the conjugate contained the apoenzyme form of transferrin, which does not bind the receptor. The conjugate followed an intracellular pathway similar to that for transferrin, remaining in low density vesicles. Degraded conjugate appeared rapidly in culture supernatants, within 5 min, and peaked by 20 min; under these conditions a T cell response to the conjugate was elicited that was consistent with an early processing compartment. Our results suggest that antigenic peptide fragments can be generated in the early endosomes, without delivery of these Ag to the lysosomes. Thus, various Ag may have differential processing requirements, dictated by their molecular nature, that determine the site of Ag processing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Inhibition of T cell responses by transferrin-coupled competitor peptides.

Authors:  Lolita Zaliauskiene; Rebecca L Fazio; Sunghyun Kang; Kerri Sparks; Casey T Weaver; Kurt R Zinn; James F Collawn
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Constitutive class I-restricted exogenous presentation of self antigens in vivo.

Authors:  C Kurts; W R Heath; F R Carbone; J Allison; J F Miller; H Kosaka
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

3.  Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.

Authors:  V R Aluvihare; A A Khamlichi; G T Williams; L Adorini; M S Neuberger
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

Review 4.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

5.  Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes.

Authors:  R N Mitchell; K A Barnes; S A Grupp; M Sanchez; Z Misulovin; M C Nussenzweig; A K Abbas
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

6.  Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.

Authors:  Mari Ohmura; Masafumi Yamamoto; Chikako Tomiyama-Miyaji; Yoshikazu Yuki; Yoshifumi Takeda; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.

Authors:  A Scardino; M Paroli; G De Petrillo; M L Michel; V Barnaba
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

8.  Antigen binding to GM1 ganglioside results in delayed presentation: minimal effects of GM1 on presentation of antigens internalized via other pathways.

Authors:  Toufic O Nashar; Zoe E Betteridge; Richard N Mitchell
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.